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Insecticide-resistant malaria vectors must be tackled
Vector control with long-lasting insecticidal nets 
and indoor residual spraying accounts for most of 
the 1·3 billion fewer malaria cases and 6·8 million 
fewer malaria-related deaths attributable to declining 
transmission between 2000 and 2015.1–3 However, 
because resistance to pyrethroid insecticides has 
spread through African malaria vector populations, 
concerns over maintaining these gains have been widely 
voiced—but these are frequently disputed.4 The findings 
presented by Natacha Protopopoff and colleagues5 in 
The Lancet provide rigorous, long overdue, new evidence 
for those working in the field of malaria vector control.
In their four-group cluster-randomised controlled trial 
in Tanzanian villages, clusters were assigned to standard 
long-lasting insecticidal nets treated with a pyrethroid 
insecticide only, long-lasting insecticidal nets treated 
with both the pyrethroid and a synergist called piperonyl 
butoxide (PBO), standard long-lasting insecticidal nets 
plus indoor residual spraying with the organophosphate 
insecticide pirimiphos-methyl, or a combination of both 
PBO long-lasting insecticidal nets and indoor residual 
spraying. While the PBO synergist added to the pyrethroid-
containing long-lasting insecticidal nets neutralises 
metabolic forms of resistance against this widely used 
insecticide class, the organophosphate used for indoor 
residual spraying belongs to a completely different 
insecticide class that local malaria vector mosquitoes 
remained fully susceptible to. This study by Protopopoff 
and colleagues5 shows conclusively that insecticide 
resistance does undermine the effects of malaria vector 
control, and that tackling it with insecticides or insecticide 
combinations to which local vectors remain susceptible 
improves impact. After 9 months of intervention, 
malaria infection prevalence was similar and consistently 
lower among children in clusters receiving PBO long-
lasting insecticidal nets (275 [31%] of 883, odds ratio 
[OR] 0·37, 95% CI 0·21–0·65; p=0·0011), standard long-
lasting insecticidal nets plus indoor residual spraying 
(252 [29%] of 877, 0·33, 0·19–0·55; p<0·0001), and PBO 
long-lasting insecticidal nets plus indoor residual spraying 
(256 [26%] of 969, 0·29, 0·17–0·49; p=0·0001) than in 
clusters receiving standard long-lasting insecticidal nets 
(515 [55%] of 932). Not only did these PBO long-lasting 
insecticidal nets achieve effects similar to standard long-
lasting insecticidal nets plus indoor residual spraying 
after 9 months, the effect was sustained after almost 
21 months of use (OR 0·40, 95% CI 0·20–0·81; p=0·0122). 
Crucially, combining PBO long-lasting insecticidal 
nets with indoor residual spraying yielded little if any 
incremental effect, and substantial redundancy was 
detected (OR 2·43, 95% CI 1·19–4·97; p=0·0158); 
therefore, a clear choice can be made between these 
options for tackling pyrethroid-resistant, indoor-biting 
mosquitoes.
PBO long-lasting insecticidal nets are expected to 
be more expensive than those with a single active 
ingredient, and no formal cost-effectiveness estimates 
or comparisons are presented by Protopopoff and 
colleagues.5 Nevertheless, although indoor residual 
spraying with expensive alternatives to pyrethroids is 
recommended for insecticide resistance management6 
and can improve malaria vector control impact,5 it has 
proven too expensive to scale up.3 So, although the shift 
to PBO long-lasting insecticidal nets presents a challenge 
to low-income countries and their public sector 
funding partners, these products probably represent a 
more realistic ambition than universal coverage with 
indoor residual spraying using prohibitive quantities 
of relatively expensive alternatives to pyrethroids. 
Also, such a shift would set an invaluable precedent 
for market entry of further long-lasting insecticidal net 
products combining two insecticide classes7 that are 
currently awaiting WHO prequalification.
While these findings are welcome, it is disappointing 
that they have only been very cautiously adopted at global 
policy level thus far.8 Although far greater investment in 
rigorous phase 3 studies is needed, these findings from 
Protopopoff and colleagues5 are in accordance with those 
of less rigorous phase 1 and phase 2 studies that preceded 
them,8 as well as predictive modelling studies exploring 
their programmatic implications.9 It remains unclear 
whether early roll-out of PBO long-lasting insecticidal nets 
could have slowed the emergence of pyrethroid-resistant 
vectors, and it is now too late to rigorously evaluate 
their potential for doing so. Although rigorous, large-
scale evaluations are indispensable, many other forms of 
evidence and societal considerations are also essential to 
rational public health decision making.10,11 Many of the 
most successful vector control interventions in history 
were progressively evaluated as they were rolled out on 
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a programmatic basis, without any preceding studies 
that would be classified as a phase 3 study today.12 Public 
health decision-making processes need to be urgently 
reformed to facilitate far more proactive investments 
in and recommendations for resistance management 
products, even when the best evidence available is less 
than completely conclusive.4
The first PBO-pyrethroid long-lasting insecticidal 
net received interim WHO approval a decade ago. 
With dual-active long-lasting insecticidal net products 
expected to enter the market shortly,7 and precious 
few new active ingredients for long-lasting insecticidal 
nets coming through the development pipeline in the 
years immediately ahead,4 there is an urgent need to 
rethink the decision-making process. How many more 
cycles of insecticide resistance and supplementation or 
replacement must the community go through? How 
many more insecticides that cost huge sums of money 
to develop must be rendered only partially effective 
or worse? And how many more preventable malaria-
related deaths must occur before stakeholders start 
making sensible decisions fast enough to maximise their 
effect on both immediate disease burden and long-term 
resistance evolution trajectories? As a community, we 
all need to act to accelerate adoption of new products 
with resistance management potential and support 
pre-emptive resistance mitigation as a strategic 
priority,4 embracing the more proactive, uncertain 
decision-making processes that will necessitate.
The process by which new products within existing, 
recommended intervention classes such as long-lasting 
insecticidal nets and indoor residual spraying receive 
recommendations from WHO needs to be much more 
rapid and decisive. Although Protopopoff and colleagues 
report a landmark study,5 it also highlights restrictions 
in the current framework for evidence review and 
recommendations. These findings should now prompt 
a more decisive WHO recommendation for widespread 
adoption of PBO long-lasting insecticidal nets 
wherever trade-offs against cost and coverage allow. 
However, they also confirm that many preventable 
malaria cases and deaths have already occurred. 
Current policy is too conservative and slow-moving, 
relying excessively on proof of incremental benefit 
in terms of epidemiological outcomes. Inevitably, 
this requirement restricts insecticide resistance 
management ambitions to reactive mitigation against 
insecticide resistance only after it has emerged with 
public health consequences big enough to measure. In 
cases where the entomological mode of action is clear, 
widely accepted, and readily measurable (eg, causing 
direct adult mosquito mortality rather than reductions 
of fecundity), evidence of incremental epidemiological 
impact should no longer be required.
If new products are to be adopted fast enough to delay 
the emergence of insecticide resistance, it is essential that 
review and recommendation policies take a bolder stance 
to emphasise pre-emptive action. If we continue waiting 
until we have all the evidence we need to be absolutely 
confident in our most important insecticide resistance 
management decisions, they will always come too late.
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